<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02786004</url>
  </required_header>
  <id_info>
    <org_study_id>124.03-2015-GES-0004</org_study_id>
    <nct_id>NCT02786004</nct_id>
  </id_info>
  <brief_title>Image Quality Assessment for Screening and Diagnostic Mammography</brief_title>
  <official_title>Mammography Image Quality Assessment Reading NextGen Images for Screening and Diagnostic Use (MAGNIFI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to determine the image quality of images using a new
      investigational medical imaging device.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image Quality Assessment by MQSA Qualified Radiologist to Access Sufficiently Acceptable Image Quality for Use in Clinical Mammography.</measure>
    <time_frame>At enrollment completion approximately 3 months post initiation</time_frame>
    <description>Overall clinical image quality was assessed as acceptable for 100% of the NextGen FFDM and DBT image sets evaluated in this study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects Experiencing a Device Related Adverse Events, Serious Adverse Event, Unanticipated Device Effect and Device Defects by Overall Occurrence.</measure>
    <time_frame>Through study completion, approximately 3 months</time_frame>
    <description>Overall clinical image quality was assessed as acceptable for 100% of the NextGen FFDM and DBT image sets evaluated in this study, and there were no AEs, SAEs, or UADEs reported in this study.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Breast Health</condition>
  <arm_group>
    <arm_group_label>Full Field Digital Mammography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2-dimensional breast imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Digital Breast Tomosynthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3-dimensional breast imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Full Field Digital Mammography</intervention_name>
    <arm_group_label>Full Field Digital Mammography</arm_group_label>
    <other_name>2D Mammography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Digital Breast Tomosynthesis</intervention_name>
    <arm_group_label>Digital Breast Tomosynthesis</arm_group_label>
    <other_name>DBT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Are women aged 40 years or older (â‰¥40 years old);

          2. Have had a FFDM (Full Field Digital Mammography) or DBT (Digital Breast Tomosynthesis)
             breast imaging exam within 30 days prior to enrollment;

          3. Have breast sizes compatible with the dimensions of a 24x29 cm image detector without
             anatomical cut-off;

          4. Are able to walk without assistive devices;

          5. Are sterile; post-menopausal; or if of childbearing potential, have a negative
             pregnancy test or is willing to provide urine sample to confirm no pregnancy, within
             30 days of imaging exam; and

          6. Are willing to provide written informed consent to participate.

        Exclusion Criteria:

          1. Have been previously included in this study or are participating in another trial
             expected to interfere with study procedures or outcomes;

          2. Have a history of breast biopsy, lumpectomy or mastectomy, or reconstruction on either
             breast;

          3. Are currently lactating;

          4. Are currently undergoing radiotherapy or chemotherapy , or have a history of prior
             radiotherapy treatment on either breast; or

          5. If enrolled to the DBT (Digital Breast Tomosynthesis) cohort, have breast implants
             (breast implants are not exclusionary in the FFDM (Full Field Digital Mammography)
             cohort).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Carolina Breast Imaging Specialist</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2016</study_first_submitted>
  <study_first_submitted_qc>May 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2016</study_first_posted>
  <results_first_submitted>June 19, 2017</results_first_submitted>
  <results_first_submitted_qc>June 19, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 21, 2017</results_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Full Field Digital Mammography</title>
          <description>2-dimensional breast imaging
Full Field Digital Mammography</description>
        </group>
        <group group_id="P2">
          <title>Digital Breast Tomosynthesis</title>
          <description>3-dimensional breast imaging
Digital Breast Tomosynthesis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Full Field Digital Mammography</title>
          <description>2-dimensional breast imaging
Full Field Digital Mammography</description>
        </group>
        <group group_id="B2">
          <title>Digital Breast Tomosynthesis</title>
          <description>3-dimensional breast imaging
Digital Breast Tomosynthesis</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Image Quality Assessment by MQSA Qualified Radiologist to Access Sufficiently Acceptable Image Quality for Use in Clinical Mammography.</title>
        <description>Overall clinical image quality was assessed as acceptable for 100% of the NextGen FFDM and DBT image sets evaluated in this study.</description>
        <time_frame>At enrollment completion approximately 3 months post initiation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Full Field Digital Mammography</title>
            <description>2-dimensional breast imaging
Full Field Digital Mammography</description>
          </group>
          <group group_id="O2">
            <title>Digital Breast Tomosynthesis</title>
            <description>3-dimensional breast imaging
Digital Breast Tomosynthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Image Quality Assessment by MQSA Qualified Radiologist to Access Sufficiently Acceptable Image Quality for Use in Clinical Mammography.</title>
          <description>Overall clinical image quality was assessed as acceptable for 100% of the NextGen FFDM and DBT image sets evaluated in this study.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects Experiencing a Device Related Adverse Events, Serious Adverse Event, Unanticipated Device Effect and Device Defects by Overall Occurrence.</title>
        <description>Overall clinical image quality was assessed as acceptable for 100% of the NextGen FFDM and DBT image sets evaluated in this study, and there were no AEs, SAEs, or UADEs reported in this study.</description>
        <time_frame>Through study completion, approximately 3 months</time_frame>
        <posting_date>06/2017</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Full Field Digital Mammography</title>
          <description>2-dimensional breast imaging
Full Field Digital Mammography</description>
        </group>
        <group group_id="E2">
          <title>Digital Breast Tomosynthesis</title>
          <description>3-dimensional breast imaging
Digital Breast Tomosynthesis</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Beth Heckel</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>262-312-7269</phone>
      <email>beth.heckel@med.ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

